BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


SEARCH JOBS










 Company News
Kite Pharma, Inc. (KITE) Announces Expanded Agreement With Tel Aviv Sourasky Medical Center And Pioneering Researcher Professor Zelig Eshhar To Develop Novel Chimeric Antigen Receptor (CAR) Approaches For Cancer Immunotherapy 1/22/2015 8:30:27 AM
Kite Pharma, Inc. (KITE) Announces Presentations Highlighting Cancer Immunotherapy T Cell Manufacturing Process 1/20/2015 7:20:45 AM
SoCal's Kite Pharma, Inc. (KITE) Talks With Insurers to Avoid Gilead Sciences, Inc. (GILD) Price War 1/15/2015 4:15:18 PM
Kite Pharma, Inc. (KITE) Expands Senior Management Team With Appointment Of Claudine Prowse, Ph.D., As SVP, Corporate Communications And Investor Relations 1/9/2015 7:36:48 AM
Kite Pharma, Inc. (KITE) Announces Addition Of Scott N. Bernstein As Vice President Of Intellectual Property Law 1/9/2015 7:30:21 AM
Kite Pharma, Inc. (KITE) Announces Exclusive License With The NIH For T Cell Receptor (TCR)-Based Products To Treat HPV-Associated Cancers 1/8/2015 7:34:56 AM
Kite Pharma, Inc. (KITE) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:05:04 AM
Kite Pharma, Inc. (KITE) Granted Orphan Drug Designation In The European Union For KTE-C19, Kite's Lead Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy 1/6/2015 10:49:30 AM
Amgen (AMGN), Kite Pharma, Inc. (KITE) Forge $1 Billion+ Cancer Immunotherapy Pact 1/5/2015 8:01:18 AM
Kite Pharma, Inc. (KITE) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 12/30/2014 7:24:10 AM
12345